You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
13 August 2026 -

Quest Diagnostics (NYSE:DGX), a provider of diagnostic information services, announced on Wednesday that its board of directors declared a quarterly cash dividend of USD0.86 per share.

This amount is unchanged from the previous quarterly dividend.

The dividend is payable on 21 October 2026 to Quest Diagnostics' common stock shareholders of record on 6 October 2026.

Login
Username:

Password:


Related Headlines

CVS Health declares unchanged quarterly dividend

Abbott declares 411th consecutive quarterly dividend

AbbVie declares quarterly dividend of USD1.73 per share

Alvotech and Lotus agree licensing deal for two biosimilar candidates

Quest Diagnostics declares quarterly dividend of of USD0.86 per share

BSF secures exclusive global commercialisation partnership for ETSYL

Saniona grants AstronauTx worldwide rights to neurological disease programme

Ridgetech reports financial results for fiscal year to March 2026

AMGEN announces Q3 2026 dividend

West Pharmaceutical Services declares quarterly dividend of USD0.22 per share

MedPal AI acquires eMARx to expand digital care home platform

Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones

Labcorp declares quarterly dividend of USD0.72 per share

Aptamer Group launches Optimer-based Ebola diagnostic programme

SK bioscience to lead Gates Foundation-funded ROTOR project

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026